Search
for
Sort by
Research 91–120 of 1000+
- Peer Review #3 of "The mediation role of sleep on the relationship between drinks behavior and female androgenetic alopecia (v0.1)"
- THE HEALTH OF HAIR : PRODUCING BEAUTIFUL HAIR
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmacogenetic approaches
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- 180 Impact of underlying medical conditions and medications on edema development in alopecia patients receiving low-dose oral minoxidil (LDOM)
- Drugs and Hair Loss
- Evaluating the role of COVID-19 vaccines in the landscape of medication-induced alopecia areata
- Cerebral Ischemia Related to Isotretinoin; Venlafaxine-Induced Alopecia; Cognitive Dysfunction with Tolterodine; Retinal Artery Occlusion after Injection of Long-Acting Risperidone; Olanzapine-Induced Chylomicronemia Presenting as Pancreatitis; Metabolic Effects of the Atypical Antipsychotics – an Editorial; Another Drug-Induced Pancreatitis – This One Caused by a Tyrosine Kinase Inhibitor; Suicide Attempts Related to Antidepressant Medications
- Effect of Scalp Micro Pigmentation(SMP) Satisfaction on Psychological Well-Bing : The Double Mediating Effects of Appearance Satisfaction and Perceived Physical Attractiveness
- Peer Review #4 of "The mediation role of sleep on the relationship between drinks behavior and female androgenetic alopecia (v0.1)"
- Olanzapine-Induced Hair Loss
- Medical and Surgical Hair Restoration
- Peer Review #7 of "The mediation role of sleep on the relationship between drinks behavior and female androgenetic alopecia (v0.1)"
- Peer Review #6 of "The mediation role of sleep on the relationship between drinks behavior and female androgenetic alopecia (v0.1)"
- Hair loss, old and uninterested nonmotor symptom in Parkinson’s disease during dopaminergic therapy
- Venlafaxine induced hair loss: a case report
- Carbamazepine-Induced Hair Loss
- Teneligliptin-induced hair loss: A case report
- Oral itraconazole for the treatment of giant tufted angioma with hair loss arising during pregnancy: A case report
- Psychiatric shades of grey: mirtazapine-induced hair discoloration and hair loss
- From Hair Loss to Vision Loss: Minoxidil-Associated CRVO in a Young Female
- Abstract 4142154: Risk of Suicide, Hair Loss, and Aspiration with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Pharmacovigilance Study from the FAERS database
- Diffuse Hair Loss Induced by Sertraline Use
- Advances in Medicalized Hair Loss Solutions: A Review of Current Clinical Practices and Regenerative Medicine-Based Protocols with Focus on Off-Label Injectable Treatments
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Diffuse scalp hair loss due to levothyroxine overdose
- Hair Transplantation in Female Pattern Hair Loss
- A case of cicatricial female pattern hair loss
- The Role of Glucagon-Like Peptide-1 Receptor Agonists in Hair Loss: Clinical Evidence and Proposed Mechanisms